Latest Healthcare Research Reports

Category: Medical Equipment

5 Key Insights On The Surgical Navigation Systems Market 2024

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Surgical Navigation Systems Global Market Report 2024, the surgical navigation systems market is expected to show significant growth in the forecast period.

The Surge of Growth in the Surgical Navigation Systems Market

In recent years, the surgical navigation systems market has experienced a rapid expansion, with a noteworthy increase from $7.84 billion in 2023 to an anticipated $9.01 billion in 2024, exhibiting a robust Compound Annual Growth Rate (CAGR) of 14.9%. This surge can be attributed to various factors, including advancements in medical imaging, a focus on patient safety, market competition, and the growing prevalence of chronic diseases, coupled with surgeons’ increasing demand for precision.

Future Projections: A Glimpse into the Next Frontier

Anticipated Growth in the Coming Years

Looking ahead, the surgical navigation systems market is poised for continued rapid growth, with a projected size of $15.29 billion in 2028 and a compound annual growth rate (CAGR) of 14.2%. The drivers of this future growth include an aging population, the demand for customized solutions, healthcare digitization, economic growth, and the increasing adoption of telemedicine and remote consultations.

The Minimally Invasive Revolution: Catalyst for Market Expansion

Minimally Invasive Surgery Driving Market Momentum

The increasing demand for minimally invasive surgical procedures stands as a significant force propelling the surgical navigation system market forward. Minimally invasive surgeries, characterized by small incisions and reduced trauma, offer numerous advantages, including less pain, shorter hospital stays, and quicker recovery times. The precision afforded by surgical navigation technologies is crucial in supporting these procedures. For example, the Cleveland Clinic reports a global increase in laparoscopic procedures, estimated to reach 1% by 2026, highlighting the growing preference for minimally invasive approaches.

Key Market Players in Minimally Invasive Surgery

Major companies in the surgical navigation systems market, such as B Braun Melsungen AG, Stryker Corporation, and Medtronic PLC, play pivotal roles in meeting the rising demand for precision in minimally invasive surgeries. These companies focus on innovation to enhance surgical navigation technologies, ensuring accurate tracking of instrument positions and projecting them onto preoperative imaging data for surgeons.

View More On The Surgical Navigation Systems Market Report 2024 – https://www.thebusinessresearchcompany.com/report/surgical-navigation-systems-global-market-report

Technological Marvels: ARVIS and Precision Surgery’s Future

ARVIS Transforming Surgical Navigation

In the quest for precision, major players in the surgical navigation systems market are introducing groundbreaking technologies. ARVIS, an augmented reality visualization and information system, takes center stage in revolutionizing precision surgery. Innovations like ARVIS aim to provide orthopedic surgeons with a hands-free, augmented reality headset during surgery, enabling accurate placement of hip and knee implants. Companies like Enovis, a USA-based medical technology company, are at the forefront of introducing such transformative technologies.

Strategic Acquisitions: Medtronic’s Leap in ENT Surgery

Medtronic’s Acquisition of Intersect ENT

In a strategic move, Medtronic PLC, an Ireland-based medical technology company, acquired Intersect ENT, Inc. for $1.1 billion in May 2022. This acquisition expands Medtronic’s product portfolio in ENT surgeries, post-operative sinus implants, surgical navigation systems, and strengthens its presence in North America. The move underscores the significance of strategic acquisitions in advancing the capabilities of companies within the surgical navigation systems market.

Segmentation and Regional Dynamics

Market Segmentation Overview

The surgical navigation systems market is segmented by technology (Electromagnetic Navigation Systems, Optical Navigation Systems, Hybrid Navigation Systems, Fluoroscopy-Based Navigation Systems, CT-Based Navigation Systems, and Other Technologies), application (Neurosurgery Navigation Systems, Orthopedic Navigation Systems, ENT Navigation Systems, Dental Navigation Systems, and Other Applications), and end user (Hospitals, Physician Practices, and Ambulatory Settings). This segmentation provides a comprehensive understanding of the diverse applications and users within the market.

Regional Insights

In 2023, North America dominated the surgical navigation systems market, highlighting the region’s technological advancements and robust healthcare infrastructure. Looking forward, Asia-Pacific is expected to emerge as the fastest-growing region in the forecast period, fueled by increasing healthcare digitization, economic growth, and a rising demand for advanced surgical technologies.

Conclusion: Navigating Precision in Surgical Procedures

In conclusion, the surgical navigation systems market is experiencing a transformative phase, driven by technological advancements, a surge in minimally invasive surgeries, and strategic initiatives. As major players innovate with technologies like ARVIS and engage in strategic acquisitions, the market is poised for continuous growth. With an aging population and a global shift towards precision surgery, the surgical navigation systems market is set to play a pivotal role in shaping the future of healthcare. Stakeholders should stay attuned to these dynamics for a strategic edge in this dynamic and evolving landscape.

Request A Sample Of The Global Surgical Navigation Systems Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=7847&type=smp

January 22, 2024
What’s The Growth Forecast For Tissue Diagnostic Market Through 2024-2033?
The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The tissue diagnostic market has experienced a remarkable surge in recent years, driven by factors such as an aging population, increased disease awareness, and technological advancements. In 2023, the market size stood at $5.27 billion, and with a projected compound annual growth rate (CAGR) of 12.3%, it is set to reach $5.92 billion in 2024. Looking ahead, the market is poised for further acceleration, reaching an impressive $9.48 billion by 2028 at a CAGR of 12.5%.

Surging Cancer Incidence Drives Expansion Of The Tissue Diagnostic Market
- Cancer’s Devastating Impact: The tissue diagnostic market is propelled by the rising incidence of cancer, where genetic changes lead to uncontrolled cell growth and tumor formation.
- Cancer Causes: Factors contributing to cancer include genetic mutations, exposure to carcinogens, smoking, obesity, radiation, and hormonal influences.
- Diagnostic Imperative: As cancer cases increase, the demand for diagnostic procedures rises, making tissue diagnostics crucial in determining disease states.
- Alarming Statistics: The American Cancer Society projected 1.9 million new cancer cases and 608,570 cancer deaths in 2021 in the USA alone.
- Key Market Players: F. Hoffmann-La Roche Ltd., Danaher Corporation, and Thermo Fisher Scientific Inc. are among the major companies shaping the tissue diagnostic market.
View More On The Tissue Diagnostic Market Report 2024 – https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report

Innovative Products Transform Tissue Diagnostic Market
- Product Innovation Trend: Key players are focusing on product innovations to gain a competitive edge, introducing solutions that automate lab operations and offer multiple testing capabilities.
- QIAGEN N.V.’s Milestone: In May 2021, QIAGEN N.V. introduced the FDA-approved Therascreen KRAS Kit, a companion diagnostic test for identifying the KRAS G12C mutation in NSCLC tumor tissue samples.
- Precision Therapy Advancements: The Therascreen KRAS Kit expands precision therapy options, exemplifying how innovative products are revolutionizing lung cancer treatment.
- Labcorp’s Strategic Move: Labcorp’s $575 million acquisition of Personal Genome Diagnostics (PGDx) in February 2022 enhances genomic profiling capabilities, especially in liquid biopsy and tissue-based products.
Market Segmentation and Emerging Trends
- Product Segmentation: The tissue diagnostic market is segmented by product type, including consumables, antibodies, kits, reagents, probes, instruments, slide staining systems, scanners, and tissue processing systems.
- Technology Advancements: Technologies such as immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special staining play a crucial role in shaping the market.
- Disease-Centric Approach: Segmentation based on diseases like breast cancer, gastric cancer, lymphoma, prostate cancer, and non-small cell lung cancer (NSCLC) offers a targeted diagnostic approach.
- End-User Landscape: Hospitals, research laboratories, pharmaceutical companies, and contract research organizations are significant end-users driving market growth.
- Regional Dominance: North America emerged as the largest region in the tissue diagnostic market in 2023, showcasing the region’s leadership in advancing diagnostic technologies.
Conclusion: Paving the Way for Precision Healthcare

The tissue diagnostic market’s exponential growth is fueled by the urgent need for advanced diagnostic solutions, particularly in the face of increasing cancer incidences. Product innovations, strategic acquisitions, and technological advancements are transforming the landscape, offering precision therapy options and expanding genomic profiling capabilities. As we look ahead, the tissue diagnostic market is not just witnessing growth in numbers; it is paving the way for a new era in precision healthcare, where early and accurate diagnostics play a pivotal role in improving patient outcomes.

Request A Sample Of The Global Tissue Diagnostic Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6505&type=smp
January 22, 2024
Growth Trajectory Of The Single-Use Assemblies Market 2024-2033
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The single-use assemblies market has witnessed exponential growth, reaching $5.1 billion in 2023, and is projected to further grow to $6.27 billion in 2024 at a CAGR of 22.9%. Key factors attributing to this growth include:
- Biopharmaceutical manufacturing
- Flexibility and cost efficiency
- Reduction of cross-contamination risks
- Regulatory compliance in biomanufacturing
- Demand for modular and plug-and-play systems
Upward Surge Continues: Forecast for 2028
The market is poised for sustained growth, projected to reach $14.16 billion in 2028, maintaining a robust CAGR of 22.6%. Anticipated contributors to this growth in the forecast period are:
- Expansion of personalized medicine
- Gene and cell therapy production
- Continuous biomanufacturing adoption
- Modular and flexible biomanufacturing facilities
- Emerging markets and global biomanufacturing hubs
- Single-use manufacturing for vaccine production
Major Trends in the Forecast Period
Emphasizing innovation, major trends include:
- Advanced sensor integration in single-use assemblies
- Iota and data analytics for bioprocess monitoring
- Automated and robotic single-use systems
- Disposable chromatography columns and membranes
- Single-use tangential flow filtration (TFF) systems
- Scalable and standardized single-use processes
Driving Forces Behind the Growth
1. Growing Demand For Biopharmaceuticals
The surge in demand for biopharmaceuticals, sophisticated medicines produced from living cells or organisms, is a significant driver. Single-use systems play a vital role in biopharmaceutical manufacturing, meeting the evolving demands of the market.
1. Increased Life Science Research and Development
Rising investments in life science R&D contribute to the growth of single-use assemblies. Notably, European pharmaceutical production reached $351 billion (€300,000 million) in 2021, with a 5% increase from the previous year, reflecting the industry’s commitment to research and development.

Key Players in the Market
Prominent companies shaping the single-use assemblies market landscape include:
- Avantor Inc.
- Corning Incorporated
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Merck KGaA
- And more…
View More On The Single-Use Assemblies Market Report 2024 – https://www.thebusinessresearchcompany.com/report/single-use-assemblies-global-market-report

Innovations Transforming the Market
1. FlexConnexx: Redefining Supply Chain Dynamics
Major companies are leveraging innovative services like FlexConnexx to gain a competitive edge. Launched by High Purity New England Inc., this service streamlines single-use assembly production, reducing lead times, and enhancing reliability within the supply chain. FlexConnexx empowers clients with dedicated facilities, expedited deliveries, and managed inventory, resembling contract development and manufacturing organizations (CDMOs).
1. Avantor’s Strategic Acquisition of Rim Bio
In June 2021, Avantor Inc. acquired RIM Bio, a China-based maker of single-use bioprocess bags and assemblies. This strategic move enhances Avantor’s capabilities in the bioproduction market, expanding its reach to the AMEA region.

Market Segmentation
The single-use assemblies market is segmented based on:
1. Product Type:
  - Filtration Assemblies
  - Bag Assemblies
  - Bottle Assemblies
  - Mixing System Assemblies
2. Solution:
  - Standard Solutions
  - Customized Solutions
3. Application:
  - Cell Culture And Mixing
  - Filtration
  - Storage
  - Sampling
  - Fill-Finish Application
4. End User:
  - Biopharmaceutical And Pharmaceutical Companies
  - Contract Research And Contract Manufacturing Organizations
  - Academic And Research Institutes
Geographical Overview
North America emerged as the largest region in the single-use assemblies market in 2023, showcasing the region’s significant contribution to the industry’s growth.

Conclusion
The single-use assemblies market is on an upward trajectory, fueled by the increasing demand for biopharmaceuticals, robust R&D investments, and innovations in assembly services. As the market continues to evolve, staying abreast of technological trends and strategic acquisitions will be pivotal for companies aiming to navigate this dynamic landscape.

Request A Sample Of The Global Single-Use Assemblies Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=7542&type=smp
January 22, 2024
5 Takeaways From The Self-Monitoring Blood Glucose (SMBG) Devices Market Overview 2024
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Self-Monitoring Blood Glucose (SMBG) Devices Global Market Report 2024, the self-monitoring blood glucose (SMBG) devices market is expected to show promising growth in the forecast period.
1. Strong Growth in Recent Years
- The self-monitoring blood glucose (SMBG) devices market has experienced robust growth, reaching $14.35 billion in 2023.
- Expected growth to $15.71 billion in 2024, boasting a CAGR of 9.5%.
- Growth contributors in the historic period: rise in diabetes prevalence, increased healthcare awareness, aging population, government initiatives, and regulations, along with a surge in healthcare spending.
1. Anticipated Strong Growth
- The market is poised for continued strong growth, projected to reach $22.15 billion in 2028.
- Forecasted CAGR of 9.0%.
- Factors driving growth in the forecast period: rising home healthcare, telehealth expansion, increased disposable income, growing demand for remote monitoring, and a rise in e-commerce.
1. Major Trends in the Forecast Period
- Integration of continuous glucose monitoring (CGM).
- Implementation of artificial intelligence (AI) and machine learning.
- Adoption of wearable SMBG devices.
- Non-invasive monitoring.
- Development of mobile apps and connectivity.
Diabetes Prevalence Propels Market Growth
1. Rising Prevalence of Diabetes
- Diabetes affects 537 million adults globally in 2021.
- Predicted to climb to 643 million by 2030 and 783 million by 2045.
- Self-monitoring blood glucose devices crucial for managing and monitoring diabetes.
- Market leaders include Abbott Laboratories, Bionime Corporation, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd., and others.
Embracing Technological Advancements
1. Non-Invasive Glucose Monitoring Devices Gain Popularity
- Technological advancement is a key trend in the market.
- Know Labs Inc. introduces KnowU, a portable non-invasive glucose monitoring device utilizing Bio-RFID technology.
- KnowU offers affordability and convenience, providing an alternative to traditional, painful monitoring devices.
1. Strategic Partnership for Smart Add-On Device
- Biocorp partners with Novo Nordisk to develop and distribute a Mallya smart add-on device for the FlexTouch pen.
- This collaboration aims to provide innovative solutions for people with diabetes.
- Novo Nordisk, a Denmark-based healthcare company, contributes to advancements in diabetes management.
Market Segmentation and Regional Overview
1. Market Segmentation
- Product: Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets
- Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers
- Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
1. Regional Dominance and Fastest-Growing Region
- North America leads the SMBG devices market in 2023.
- Europe expected to be the fastest-growing region in the forecast period.
Conclusion: Transforming Diabetes Management
The self-monitoring blood glucose devices market stands at the forefront of healthcare innovation, addressing the rising prevalence of diabetes globally. With a strong historical growth trajectory and anticipated advancements in technology, the market not only supports diabetes management but also enhances the quality of life for individuals. As the market continues to evolve, embracing non-invasive monitoring and strategic collaborations, it remains a beacon of hope for diabetics worldwide. The future promises a more connected, technologically advanced landscape, offering personalized solutions for effective diabetes care.

View More On The Self-Monitoring Blood Glucose (SMBG) Devices Market Report 2024 – https://www.thebusinessresearchcompany.com/report/self-monitoring-blood-glucose-smbg-devices-global-market-report

Request A Sample Of The Global Self-Monitoring Blood Glucose (SMBG) Devices Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6969&type=smp
January 22, 2024
Key Trends And Drivers In The Single-Chamber Prefilled Syringes Market 2024

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The Single-Chamber Prefilled Syringes Market Surge
The single-chamber prefilled syringes market has witnessed a remarkable expansion, reaching $9.74 billion in 2023 and projecting further growth to $11 billion in 2024, boasting a robust Compound Annual Growth Rate (CAGR) of 13.0%. The momentum is expected to persist, with a forecasted market size of $19.22 billion in 2028 at an accelerated CAGR of 15.0%. The drivers of this growth include various factors spanning the pharmaceutical and biotechnology sectors, patient-friendly drug administration, safety and ease of use, demand for precise drug dosing, regulatory approvals, and guidelines.

Understanding the Growth Drivers
Rising Prevalence of Chronic Diseases Fuels Single-Chamber Prefilled Syringes Market Growth
The upswing in chronic diseases, notably diabetes and cancer, is a primary catalyst for the growth of the single-chamber prefilled syringe market. Notably, the increasing prevalence of diabetes, with projections reaching 643 million by 2030 and 783 million by 2045, underscores the critical role of prefilled syringes in insulin therapy. Similarly, the American Cancer Society’s prediction of 1.9 million new cancer cases in 2021 emphasizes the growing demand for prefilled syringes in cancer treatments.

Key Market Players
Major companies contributing to the growth of the single-chamber prefilled syringes market include Becton, Dickinson and Company, Gerresheimer Glass Inc., Schott AG, Catalent Inc., Nipro Medical Corporation, and more. These industry players are at the forefront, driving innovation and meeting the evolving needs of patients and healthcare providers.

Read More On The Single-Chamber Prefilled Syringes Market Report 2024 – https://www.thebusinessresearchcompany.com/report/single-chamber-prefilled-syringes-global-market-report

Market Focus On Generic Injectable Medications
Major Players and Generic Injectable Medications
Leading companies in the market are strategically concentrating on the development of generic injectable medicines to enhance their product portfolios. Noteworthy among these is Hikma Pharmaceuticals PLC, which introduced the first FDA-approved pre-filled syringe for Succinylcholine Chloride Injection in October 2022. This generic injectable medication plays a vital role in hospital settings for general anesthesia, tracheal intubation, and inducing muscle relaxation during surgical procedures or mechanical ventilation.

Strategic Acquisitions and Portfolio Expansion
Nordic Pharma Group’s Acquisition
In January 2022, Nordic Pharma Group acquired the ALTIM (cortivazol) pre-filled syringe from Sanofi S.A. This strategic move aligns with Nordic Pharma’s objectives of expanding its proprietary product portfolio and establishing a significant presence in the rheumatology field. Sanofi S.A., a notable player in the pharmaceutical industry, is actively involved in the development of prefilled syringes, contributing to the market’s growth.

Segmentation and Regional Dynamics
Segmentation Overview
The single-chamber prefilled syringes market is segmented by type (Glass, Plastic) and application (Vaccine Product, Biologic, Pharmaceutical Product). This segmentation allows for a more nuanced understanding of the market landscape, catering to diverse healthcare needs.

Dominance of North America
In 2023, North America emerged as the largest region in the single-chamber prefilled syringes market. The region’s prominence is driven by factors such as technological advancements, a robust healthcare infrastructure, and a high prevalence of chronic diseases, creating a conducive environment for market growth.

Future Trends and Innovations
Anticipated Trends in the Forecast Period
Looking ahead, several trends are expected to shape the landscape of the single-chamber prefilled syringes market. These include the integration of connected devices, the use of sustainable and biodegradable materials, the emergence of customized and patient-specific syringe options, needlestick prevention and safety features, and the application of prefilled syringes in cell and gene therapies. Additionally, the market is witnessing a surge in anti-counterfeiting measures to ensure the safety and authenticity of pharmaceutical products.

Conclusion
In conclusion, the single-chamber prefilled syringes market is experiencing robust growth, driven by factors such as the rising prevalence of chronic diseases, strategic acquisitions, a focus on generic injectable medications, and innovative trends. As the market continues to evolve, it is poised for further expansion, providing crucial solutions for drug delivery in various healthcare settings. Stakeholders, including pharmaceutical companies and healthcare providers, should closely monitor these trends and developments to capitalize on the opportunities presented by this dynamic and growing market.

Request for A Sample Of The Global Single-Chamber Prefilled Syringes Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=5419&type=smp

January 22, 2024
Global Sample Preparation Market Analysis: Estimated Market Size And Growth Rate

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

In recent years, the sample preparation market has witnessed robust growth, with its size surging from $8.75 billion in 2023 to an estimated $9.38 billion in 2024, exhibiting a compelling Compound Annual Growth Rate (CAGR) of 7.2%. This upward trajectory can be attributed to various factors, including the flourishing fields of life sciences research and diagnostics, drug discovery and development, clinical and molecular diagnostics, academic and government funding, and the expansive growth of the biotechnology and pharmaceutical industry.

Anticipating Strong Growth Ahead
Looking to the Future: Projected Growth
The sample preparation market is poised for continued strong growth, with a forecasted size of $12.79 billion in 2028, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.1%. The drivers of this anticipated growth include key factors such as high-throughput sample preparation automation, sample preparation for single-cell analysis, liquid biopsy sample preparation, point-of-care and at-home testing, emerging markets and research initiatives, and the integration of AI-driven sample preparation protocols.

Fueling Growth: Research and Development Investments in Pharmaceuticals
R&D Investments as a Catalyst
A significant catalyst for the future growth of the sample preparation market is the substantial increase in research and development (R&D) investments within the pharmaceutical industry. In pharmaceutical analyses, the need for efficient sample preparation procedures is paramount, as most analytical instruments cannot directly handle complex matrices. The National Centre for Biotechnology Information reports a 7.7% increase in pharmaceutical spending in 2021, reaching $576.9 billion in the US. As R&D spending in pharmaceuticals continues to rise, reaching $12.79 billion in 2028, it is expected to play a pivotal role in propelling the sample preparation market forward.

View More On The Sample Preparation Market Report 2024 – https://www.thebusinessresearchcompany.com/report/sample-preparation-global-market-report

Innovations Shaping the Landscape: Fusion Sample Preparation Systems
Product Innovations Redefining Sample Preparation
Major players in the sample preparation market are at the forefront of innovation, introducing fusion sample preparation systems to enhance their market competitiveness. These advanced laboratory tools automate and optimize the process of combining and preparing samples for analytical or scientific purposes. A notable example is Malvern Panalytical’s FORJ™, launched in April 2023. This fusion sample preparation system offers reduced thermal stress, stable heating for consistent results, operator accessibility, flexibility, and a substantial productivity boost of up to 25%, setting a new standard in elemental analysis.

Strategic Acquisitions: Pacific Biosciences’ Move for Expansion
Strategic Acquisition for Enhanced Capabilities
In a strategic move, Pacific Biosciences, a US-based biotechnology company, acquired Circulomics Inc. in August 2021. This acquisition aimed to bolster Pacific Biosciences’ capacity for extraction and sample preparation, offering a simpler route toward an end-to-end automated workflow. Circulomics Inc., a US-based biotechnology startup, specializes in providing distinctive sample preparation solutions supporting genomic workflows. This strategic move reflects the importance of acquisitions in expanding capabilities within the sample preparation market.

Segmentation and Regional Dynamics
Market Segmentation and Regional Insights
The sample preparation market is segmented by product (Sample Preparation Instruments, Consumables, Sample Preparation Kit), application (Proteomics, Genomics, Epigenomics, Other Applications), and end user (Pharmaceutical, Biotechnology, Molecular Diagnostics, Other End Users). This segmentation provides a comprehensive understanding of the diverse products, applications, and end users within the market. In 2023, North America emerged as the largest region in the sample preparation market, showcasing its technological advancements. Looking ahead, Asia-Pacific is projected to be the fastest-growing region in the forecast period, driven by emerging markets and increased research initiatives.

Conclusion: Paving the Way for Advanced Analysis
In conclusion, the sample preparation market is experiencing significant growth driven by R&D investments in pharmaceuticals, product innovations, and strategic acquisitions. As major players introduce fusion sample preparation systems and expand their capabilities through acquisitions, the market is poised for sustained expansion. With a focus on emerging trends such as miniaturized devices, CRISPR-based gene editing, and sustainable materials, the sample preparation market is set to revolutionize analytical processes. Stakeholders in the pharmaceutical, biotechnology, and diagnostic industries should closely monitor these dynamics to capitalize on the evolving landscape of sample preparation technologies.

Request A Sample Of The Global Sample Preparation Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=5302&type=smp

January 22, 2024
5 Key Insights On The RNA Analysis Or Transcriptomics Market 2024
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s RNA Analysis Or Transcriptomics Global Market Report 2024, the RNA analysis or transcriptomics market is expected to show significant growth in the forecast period.

Introduction: A Rapidly Expanding Frontier The RNA analysis/transcriptomics market has experienced robust growth, surging from $6.89 billion in 2023 to an anticipated $7.91 billion in 2024, with a compound annual growth rate (CAGR) of 14.9%. This expansion is rooted in historical drivers such as cancer research, precision medicine, drug discovery, infectious disease diagnostics, personalized medicine, and substantial funding from academic and government sources.

Anticipating Rapid Growth: A Glimpse into the Future Looking ahead, the RNA analysis/transcriptomics market is poised for rapid growth, projected to reach $14.2 billion in 2028 with a CAGR of 15.7%. Key factors contributing to this surge include single-cell RNA sequencing applications, integration of RNA analysis in clinical diagnostics, RNA-based therapies and vaccines, advanced bioinformatics tools, and biomarker discovery. The forecast period also promises intriguing trends like spatial transcriptomics, long-read RNA sequencing, RNA editing analysis, AI integration in RNA data analysis, RNA therapeutics for rare diseases, and RNA-based liquid biopsy for cancer detection.

Driving Force: Personalized Medicine Ignites Market Growth
- Definition of Personalized Medicine: The rising demand for personalized medicine is a pivotal factor driving the growth of the RNA analysis/transcriptomics market. Personalized medicine involves tailoring medical treatment to individual patient characteristics.
- Scope and Impact: With over 75,000 genetic testing products and 300 personalized medicines expected to hit the market, the demand for personalized care is poised to propel the RNA analysis market forward.
- PMC Insight: According to the Personalized Medicine Coalition (PMC), the broad application of personalized medicine spans multiple cancer types, genetic rare diseases, and various chronic and infectious diseases.
Market Leaders and Innovators
- Key Companies: Major players in the RNA analysis/transcriptomics market include Illumina Inc., Thermo Fisher Scientific Inc., Roche Ltd., and Agilent Technologies Inc.
- Technological Advances: Innovations such as next-generation sequencing (NGS) and RNA interference (RNAi) have significantly improved precision and accuracy in RNA analysis.
View More On The RNA Analysis Or Transcriptomics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Technological Advancements Drive RNA Analysis Innovations
- NGS Technology: Illumina’s Next-generation sequencing (NGS) is a breakthrough technology that fragments DNA/RNA, adds adapters, sequences libraries, and reassembles them to form a genomic sequence.
- Precision and Accuracy: These technological advancements enhance the precision and accuracy of RNA analysis, allowing researchers to delve into transcriptional activity with unprecedented detail.
Strategic Partnerships and Collaborations Foster Progress
- Collaborative Endeavors: Major companies are actively engaging in strategic partnerships and collaborations to enhance RNA library preparation kits, empowering specialized workflows.
- Case in Point: Singular Genomics Systems Inc. partnered with Lexogen to demonstrate the G4 sequencing platform’s compatibility with Lexogen’s RNA research products, streamlining NGS workflows for customers.
Market Segmentation: Tailoring Solutions for Diverse Needs
- Product Types: Segmentation includes reagents/consumables, instruments, and software.
- Technology Segments: Categories such as microarrays, sequencing, polymerase chain reaction, and RNA interference cater to diverse technological preferences.
- Application Spectrum: The market serves clinical diagnostics, drug discovery, toxicogenomics, comparative transcriptomics, and RNA interference applications.
Regional Dominance: North America Takes the Lead
- Market Share: In 2023, North America emerged as the largest region in the RNA analysis/transcriptomics market, with significant contributions from companies like Illumina Inc. and Thermo Fisher Scientific Inc.
Conclusion: Unveiling the Future of RNA Analysis The RNA analysis/transcriptomics market is evolving at a remarkable pace, driven by the rising demand for personalized medicine, technological advancements, and strategic collaborations. As the industry embraces innovations such as spatial transcriptomics, long-read RNA sequencing, and AI integration, it is not merely growing but unfolding a future where RNA analysis plays a pivotal role in revolutionizing diagnostics, therapeutics, and the understanding of intricate biological processes.

Request A Sample Of The Global RNA Analysis Or Transcriptomics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=5241&type=smp
January 22, 2024
Global Sterilization Equipment Market Key Insights 2024-2033
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Sterilization Equipment Global Market Report 2024, the sterilization equipment market is expected to show promising growth in the forecast period.

The sterilization equipment market has experienced robust growth in recent years, driven by factors such as the rising demand for infection control measures, awareness of regulatory requirements, and the expanding applications across diverse industries. In 2023, the market size reached $12.18 billion, with a projected compound annual growth rate (CAGR) of 11.6%, set to reach $13.59 billion in 2024. Looking ahead, the market is poised for rapid expansion, reaching an impressive $22.14 billion by 2028 at a CAGR of 13.0%.

Increasing Surgical Procedures Anticipated To Fuel Sterilization Equipment Market
- Surgical Procedure Surge: The sterilization equipment market is expected to be propelled by the increasing number of surgical procedures worldwide.
- Role of Sterilization Equipment: Sterilization equipment ensures that instruments and tools used in surgical procedures are free from microorganisms, preventing infections.
- Plastic Surgery Boom: A 54% surge in US plastic surgery operations in 2021, as reported by the Aesthetic Society, signifies the growing demand for surgical procedures.
- Market Driving Force: The surge in surgical procedures, from plastic surgery to more complex operations, is a key driving force behind the growth of the sterilization equipment market.
Innovative Solutions to Boost Efficiency in Sterilizing Surgical Equipment
- Innovative Product Launches: Major companies in the sterilization equipment market are introducing groundbreaking solutions to enhance efficiency in sterilizing surgical equipment trays in hospitals.
- Simultaneous Sterilization Wrap: Ahlstrom-Munksjö launched Reliance Fusion, a simultaneous sterilization wrap that combines cellulose and polypropylene materials for enhanced efficiency.
- Faster Drying and Reduced Wet Packs: Reliance Fusion integrates wet-laid technology with high-filtration SMS, resulting in faster drying, fewer wet packs, and increased sterilization efficiency.
- Reduced Need for Multiple Wrap Types: The portfolio offers two wrap options, Reliance Fusion Light for light-to-medium duty, and Reliance Fusion Heavy for heavy-duty, reducing the need for multiple wrap types.
View More On The Sterilization Equipment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/sterilization-equipment-global-market-report

Ellab’s Strategic Acquisition to Bolster Sterilization Services
- Strategic Acquisition: In July 2022, Ellab, a Denmark-based provider of validation, monitoring, and calibration solutions, acquired Causa to strengthen its field services in key markets.
- Focus on Qualification and Validation Services: Causa, a Dutch-based company acquired by Ellab, specializes in qualification and validation services with a focus on sanitization and sterilizing equipment.
- Global Market Expansion: Ellab’s acquisition of Causa is a strategic move to expand its presence and enhance its sterilization services in key markets globally.
Market Segmentation and Emerging Trends
- Product Segmentation: Sterilization indicators, detergents, pouches, lubricants, and sterilization accessories form key product categories in the sterilization equipment market.
- Equipment Types: High-temperature sterilization, low-temperature sterilization, filtration sterilization, and ionizing radiation sterilization are critical equipment categories.
- Diverse End Users: Pharmaceutical companies, hospitals and clinics, medical device companies, food and beverage companies, and other end users contribute to the market’s diversity.
- Regional Dynamics: North America emerged as the largest region in the sterilization equipment market in 2023, with Asia-Pacific anticipated to be the fastest-growing region in the forecast period.
Conclusion: Shaping a Safer Future in Healthcare
As the sterilization equipment market continues to flourish, driven by innovative solutions and strategic acquisitions, it plays a crucial role in shaping a safer future for healthcare. The surge in surgical procedures, coupled with advancements in sterilization technologies, underscores the industry’s commitment to ensuring the highest standards of infection control. With the forecasted rapid growth and ongoing trends like miniaturization, automation, and wireless connectivity, the sterilization equipment market is set to be at the forefront of ensuring the safety and well-being of patients across the globe.

Request A Sample Of The Global Sterilization Equipment Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=5918&type=smp
January 22, 2024
Future Growth Forecast For The Small Animal Imaging (In-Vivo) Global Market 2024-2033
The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The small animal imaging (in-vivo) market has witnessed remarkable growth, evolving from $2.59 billion in 2023 to a projected $2.91 billion in 2024 at an impressive CAGR of 12.6%. Projections indicate continued expansion, with an estimated market size of $4.55 billion by 2028, boasting a CAGR of 11.8%. What fuels this growth, and what trends and technologies are steering the market forward?

Rapid Growth Catalysts in Recent Years
- Preclinical Research and Drug Development: The market’s historical growth was fueled by a surge in preclinical research and drug development activities.
- Pharmaceutical and Biotechnology Sectors Expansion: The market benefited from the expanding pharmaceutical and biotechnology sectors.
- Translational Research and Disease Modeling: The growth was further driven by increased focus on translational research, disease modeling, and pathophysiology studies.
- Academic and Government Funding: Robust support from academic institutions and government funding for research played a crucial role in market expansion.
Forecasts and Emerging Trends
- Development of Novel Imaging Probes: Anticipated growth in the forecast period can be attributed to the development of novel imaging probes and tracers.
- Expansion of Preclinical CROs: The integration of Contract Research Organizations (CROs) into preclinical research contributes significantly to market expansion.
- Integration of AI in Image Analysis: The incorporation of Artificial Intelligence (AI) in image analysis is a key trend, enhancing efficiency and accuracy.
- Advanced Multimodal Imaging Systems: The adoption of advanced multimodal imaging systems contributes to more comprehensive and insightful data collection.
- 3D and High-Resolution Imaging: The market is witnessing a surge in demand for 3D and high-resolution imaging for small animals.
Key Trends Shaping the Forecast Period
- Molecular and Functional Imaging: The forecast period sees a significant focus on molecular and functional imaging in small animals.
- Longitudinal and Real-Time In-Vivo Imaging: Researchers are increasingly turning to longitudinal and real-time in-vivo imaging techniques.
- Hybrid Imaging Modalities: Integration of hybrid imaging modalities provides a wealth of multimodal information.
- CRISPR-Edited Animal Imaging: Researchers are utilizing imaging techniques for studying CRISPR-edited animals, facilitating genetics research.
- AI-Driven Phenotyping and Biomarker Discovery: Artificial intelligence is playing a pivotal role in phenotyping and biomarker discovery.
- Imaging for Neurodegenerative Diseases: There is a growing emphasis on utilizing imaging for research related to neurodegenerative diseases and neuroscience.
Chronic Diseases as Growth Drivers
- Elevated Incidence: The surge in chronic diseases, projected to increase by 99.5% among individuals aged 50 and older by 2050, is a significant driver.
- Role of Small Animal Imaging Techniques: Micro-CT, micro-MRI, and micro-PET play a crucial role in preclinical research, aiding in understanding disease mechanisms and testing novel therapies.
- Market Growth Implication: The rise in chronic diseases is expected to propel the small animal imaging (in-vivo) market forward.
Major Players and Market Segmentation
- Key Companies: Leading companies in the market include Bruker Corporation, PerkinElmer Inc., Miltenyi Biotec GmbH, Siemens AG, and others.
- Market Segmentation:
  - By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components.
  - By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics.
  - By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers.
View More On The Small Animal Imaging (In-Vivo) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Technological Advancements Fueling Growth
- Automated Advanced Technology Ultrasound: PerkinElmer’s Vega imaging system, launched in April 2022, exemplifies the market’s focus on advanced technology.
- Rigaku Corporation’s Strategic Acquisition: Rigaku Corporation’s acquisition of MILabs B.V. in August 2021 exemplifies strategic moves to expand life sciences modality business.
Regional Dynamics
- North America Leading: North America emerged as the largest region in the small animal imaging (in-vivo) market in 2023.
- Europe’s Growth Prospects: Europe is anticipated to be the fastest-growing region in the forecast period.
Conclusion: A Dynamic Future Awaits
The small animal imaging (in-vivo) market is on an upward trajectory, driven by factors such as technological advancements, increased research in chronic diseases, and innovative imaging modalities. As the market continues to evolve, it promises a dynamic future, marked by transformative technologies and a deeper understanding of preclinical research and disease mechanisms. Researchers, industry players, and investors alike are poised to benefit from the vibrant landscape that the small animal imaging market presents.

Request A Sample Of The Global Small Animal Imaging (In-Vivo) Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=7303&type=smp
January 22, 2024
Dental Crown And Bridges Market Forecast 2023-2032: Size, Key Players And Segments

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

North America held the largest dental crown and bridges market share, and Asia-Pacific was the fastest-growing region in 2022.

The global dental crown and bridges market is expected to grow from $4 billion in 2022 to $4.44 billion in 2023 at a compound annual growth rate (CAGR) of 11.1%. The dental crown and bridges market size is expected to grow to $6.12 billion in 2027 at a CAGR of 8.4%.

Major Driver In The Dental Crown And Bridges Market – Increase In The Prevalence Of Oral Diseases
According to a report issued in 2022 by the Ministry of Health and Family Welfare, dental caries, or tooth decay, affects over 60% of the Indian population, whereas periodontal disease affects approximately 85% of the Indian population. As a result, the rising prevalence of oral disorders will propel the dental crown and bridge market forward.

View More On The Dental Crown And Bridges Market Report 2023 – https://www.thebusinessresearchcompany.com/report/dental-crown-and-bridges-global-market-report

Key Dental Crown And Bridges Market Segments
1) By Type: Crowns, Bridges
2) By Material: Ceramics, Porcelain Fused To Metals, Metals
3) By Price: Premium, Value, Discounted
4) By End User: Dental Hospitals And Clinics, Dental Laboratories, Other End Users

Recent Dental Crown And Bridges Market Trend – Emerging Robotic Surgeries
As technology and computer science progress, robotics are increasingly being used in navigational surgery for a wide range of medical specialisations. For putting apparatus, robotics offers advantages over freehand methods in dentistry, boosting accuracy, precision, workflows, and patient results. For example, Neocis, a US-based business specialised in robot-assisted dental implant surgery, will debut YomiPlan Go in August 2022. YomiPlan Go is a robotic workflow that combines the control and precision of robotic guidance with the flexibility and speed of freehand surgery. YomiPlan Go determines the depth of the fracture and avoids over drilling by using the fundamental drill bit and implant specifications entered by the clinical team. It also allows for gingival thickness or subcrestal implant implantation with the help of an easy-to-use depth offset tool.

Dental Crown And Bridges Market Prominent Players
Major players in the dental crown and bridges market are 3M, Ivoclar Vivadent, Dentsply International Inc., Nobel Biocare Services, BioHorizons, Camlog Holding, Straumann, Zimmer Biomet, Wieland Dental, National Dentex Lab, Henry Schein Inc., Glidewell, Dentium, Biotech Dental, Danaher Corporation, Osstem Implant, Derby Dental, Lithoz, Align Technology, LASAK s.r.o., AMT s.r.l., Sirona Dental system, and Formlabs.

Request A Sample Of The Global Dental Crown And Bridges Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5814&type=smp

The Dental Crown And Bridges Global Market Report 2023 provides a comprehensive overview on the dental crown and bridges market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the dental crown and bridges market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

A dental bridge is a prosthetic device used to repair individuals who have lost teeth. Bridges are made of porcelain that has been bonded to metal in order to improve chewing ability and tooth aesthetics.

View More Related Reports –
Dental Implants And Prosthetics Global Market Report 2023
Dental Equipment And Supplies Global Market Report 2023
Dental Diagnostic Imaging Devices And Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

January 20, 2024